ARCHIVES

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

New ACR Mammography Guidelines Suggest Annual Screening For Women Age 40-50

November 12, 1982

Silicone Implants Not Linked To Increased Risk Of Death

May 25, 2001

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009